These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3212599

  • 1. [Capillary microscopic effect of naftidrofuryl in peripheral arterial occlusive disease].
    Heidrich H, Ranft J.
    Vasa Suppl; 1988; 24():17-20. PubMed ID: 3212599
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of naftidrofuryl on creatinine serum concentration and on PAH/inulin clearance in peripheral arterial occlusive diseases].
    Heidrich VH, Baethke R, Beyer KH.
    Arzneimittelforschung; 1975 Mar; 25(3):429-31. PubMed ID: 1174049
    [Abstract] [Full Text] [Related]

  • 3. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
    Horsch S.
    Vasa Suppl; 1988 Mar; 24():38-43. PubMed ID: 3212602
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].
    Abendroth D, Sunder-Plassmann L.
    Vasa Suppl; 1988 Mar; 24():33-7. PubMed ID: 3212601
    [No Abstract] [Full Text] [Related]

  • 5. [Thrombocyte function in parenteral naftidrofuryl therapy].
    Janka HU, Rinninger F, Mehnert H.
    Ther Ggw; 1982 Jul; 121(7):422-33. PubMed ID: 7051401
    [No Abstract] [Full Text] [Related]

  • 6. [Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
    Ratschow R.
    MMW Munch Med Wochenschr; 1976 Sep 03; 118(36):1131-4. PubMed ID: 823407
    [Abstract] [Full Text] [Related]

  • 7. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
    Ranft J, Heidrich H, Lammersen T.
    J Mal Vasc; 1987 Sep 03; 12(1):78-81. PubMed ID: 3559415
    [Abstract] [Full Text] [Related]

  • 8. [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].
    Maass U, Amberger HG, Böhme H, Diehm C, Dimroth H, Heidrich H, Heinrich F, Hirche H, Mörl H, Müller-Bühl U.
    Dtsch Med Wochenschr; 1984 May 11; 109(19):745-50. PubMed ID: 6373217
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of naftidrofuryl (praxilene) on the peripheral cerebral circulation. Dynamometric and dynamographic control].
    Barut C, Roch MT.
    Bull Soc Ophtalmol Fr; 1974 May 11; 74(7-8):771-8. PubMed ID: 4469472
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vascular effects of naftidrofuryl in a randomized placebo-controlled double-blind study.
    Jung F, Wolf S, Kiesewetter H.
    Arzneimittelforschung; 1989 Oct 11; 39(10):1277-80. PubMed ID: 2610721
    [Abstract] [Full Text] [Related]

  • 19. [Comparative study of femoral vasodilatator effects of naftidrofuryl and nicergoline on dog (author's transl)].
    Luong TN, Depin JC.
    J Pharmacol; 1981 Oct 11; 12(3):263-75. PubMed ID: 7289623
    [Abstract] [Full Text] [Related]

  • 20. Effect of naftidrofuryl oxalate (praxilene) on peripheral circulation measured by calorimetry.
    Tan OT, Gaylarde PM, Sarkany I.
    Australas J Dermatol; 1978 Aug 11; 19(2):51-3. PubMed ID: 728015
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.